Clinical trial

Possible Role of Roflumilast in Diabetic Nephropathy

NCT04755946

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-03-10

PhasePHASE3

Study timeline

Study start (estimated)2021-03-10Date precision: day

Registry last updated2021-02-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Nephropathiesunresolved

Interventions

RoflumilastDRUG · verified · RxNorm: roflumilast

PlaceboDRUG

Sponsors & collaborators

Tanta Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04755946 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.